ENOXAPARIN SODIUM

Generic: ENOXAPARIN SODIUM

BE Pharmaceuticals Inc.Manufacturer
SUBCUTANEOUSRoute
ENOXAPARIN SODIUMActive Substance
2023-06-06Original Approval

ENOXAPARIN SODIUM is FDA application ANDA214646, sponsored by BE PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
1,048 reports
2
DYSPNOEA
996 reports
3
DIARRHOEA
951 reports
4
NAUSEA
942 reports
5
PYREXIA
905 reports
6
ANAEMIA
834 reports
7
VOMITING
796 reports
8
FATIGUE
749 reports
9
THROMBOCYTOPENIA
746 reports
10
PNEUMONIA
697 reports